Clinical and Cognitive Sciences Research Group, Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Salford Royal Hospital, Salford M6 8HD, UK.
Acta Neuropathol Commun. 2013 Oct 14;1:68. doi: 10.1186/2051-5960-1-68.
Cases of Frontotemporal Lobar Degeneration (FTLD) and Motor Neurone Disease (MND) associated with expansions in C9ORF72 gene are characterised pathologically by the presence of TDP-43 negative, but p62 positive, inclusions in granule cells of the cerebellum and in cells of dentate gyrus and area CA4 of the hippocampus.
We screened 84 cases of pathologically confirmed FTLD and 23 cases of MND for the presence of p62 positive inclusions in these three brain regions, and identified 13 positive cases of FTLD and 3 of MND. All cases demonstrated expansions in C9ORF72 by Southern blotting where frozen tissues were available. The p62 positive inclusions in both cerebellum and hippocampus were immunostained by antibodies to dipeptide repeat proteins (DPR), poly Gly-Ala (poly-GA), poly Gly-Pro (poly-GP) and poly Gly-Arg (poly-GR), these arising from a putative non-ATG initiated (RAN) sense translation of the GGGGCC expansion. There was also some slight, but variable, immunostaining with poly-AP antibody implying some antisense translation might also occur, though the relative paucity of immunostaining could reflect poor antigen avidity on the part of the antisense antibodies. Of the FTLD cases with DPR, 6 showed TDP-43 type A and 6 had TDP-43 type B histology; one had FTLD-tau with the pathology of corticobasal degeneration. There were no qualitative or quantitative differences in the pattern of immunostaining with antibodies to DPR, or p62, proteins between TDP-43 type A and type B cases. Ratings for frequency of inclusions immunostained by these poly-GA, poly-GP and poly-GR antibodies broadly correlated with those for immunolabelled by p62 antibody in all three regions.
We conclude that DPR are a major component of p62 positive inclusions in FTLD and MND.
伴有 C9ORF72 基因扩增的额颞叶变性(FTLD)和运动神经元病(MND)病例在病理学上的特征是小脑颗粒细胞和齿状回及海马 CA4 区的细胞中存在 TDP-43 阴性但 p62 阳性的包涵体。
我们筛选了 84 例经病理证实的 FTLD 病例和 23 例 MND 病例,以确定这三个脑区是否存在 p62 阳性包涵体,结果发现 13 例 FTLD 病例和 3 例 MND 病例阳性。所有病例均通过 Southern 印迹法证实存在 C9ORF72 扩增,且在有冷冻组织的情况下。小脑和海马中的 p62 阳性包涵体均被二肽重复蛋白(DPR)、聚甘氨酸-丙氨酸(poly-GA)、聚甘氨酸-脯氨酸(poly-GP)和聚甘氨酸-精氨酸(poly-GR)抗体免疫染色,这些 DPR 来自 GGGGCC 扩增的假定非 ATG 起始(RAN)有义翻译。用聚-AP 抗体也有一些轻微但可变的免疫染色,这表明可能也存在一些反义翻译,但免疫染色相对较少可能反映出反义抗体的抗原亲和力较差。在具有 DPR 的 FTLD 病例中,6 例为 TDP-43 型 A,6 例为 TDP-43 型 B 组织学;1 例为 FTLD-tau,其病理学表现为皮质基底节变性。TDP-43 型 A 和 B 病例的 DPR 或 p62 蛋白抗体免疫染色模式无定性或定量差异。这些聚-GA、poly-GP 和 poly-GR 抗体标记的包涵体的频率评分与在所有三个区域中用 p62 抗体标记的包涵体大致相关。
我们的结论是,DPR 是 FTLD 和 MND 中 p62 阳性包涵体的主要成分。